Overview

A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone

Status:
Completed
Trial end date:
2019-11-08
Target enrollment:
Participant gender:
Summary
A Study in Healthy Male Subjects Designed to Evaluate the Pharmacokinetic Profile of Abiraterone Following Administration of Immediate Release Formulations
Phase:
Phase 1
Details
Lead Sponsor:
Zentiva, k.s.
Treatments:
Abiraterone Acetate